Home | Sitemap | Search | Contact A- A A+
   
English
 
    Public Member Support us  
 
About IBCSG
Patients & Public
Health Professionals
Open Trials
Closed Trials
Trial I
Trial II
Trial III
Trial IV
Trial V
Trial VI
Trial VII
Trial VIII
Trial IX
IBCSG 10-93
IBCSG 11-93
IBCSG 12-93
IBCSG 13-93
IBCSG 14-93
IBCSG 15-95
IBCSG 16-98
IBCSG 17-98
IBCSG 18-98
IBCSG 19-01
IBCSG 20-98
IBCSG 21-99
IBCSG 22-00
IBCSG 23-01
IBCSG 24-02
IBCSG 25-02
IBCSG 26-02
IBCSG 27-02
IBCSG 28-02
IBCSG 29-03
IBCSG 30-04
IBCSG 32-05
IBCSG 33-03
IBCSG 34-05
IBCSG 35-07
IBCSG 36-07
IBCSG 37-07
Tissue Bank / Translational Research
Home > Public > Health Professionals > Closed Trials > Trial IV

Trial IV 

Adjuvant therapy for postmenopausal; 65 years of younger, node positive breast cancer patients: observation vs. prednisone + tamoxifen vx. prednisone + tamoxifen

DESIGN

Design Trial IV

Results & Publications

Presentations

Publications
Study Chair
Prof. Aron Goldhirsch - Milano, Italy

Statistician
Karen Price

Trial Coordinators
Holly Shaw

Data Managers
Tara Scolese, Dawn Weinbaum

IBCSG Data Management Center/FSTRF
4033 Maple Road
Amherst, New York 14226 USA
Phone: +1 716 834 0900
Fax: +1 716 836 6097
Email: ibcsgI-IV@fstrf.org

Date of Activation
July 1, 1978

Date of Closure
September 1, 1981

Final Accrual
1713 patients (1601 evaluable patients)
Results Publications Results & Publications

News

21.05.2013:
A few impressions from our audits

10.04.2013:
New publications are available

19.03.2013:
The next  IBCSG Annual Meeting will take place in Glasgow, Scotland on March 21nd and 22th, 2014.

All News

  
  Print
Disclaimer | Copyright